| Q36484624 | (1)H NMR based profiling of spent culture media cannot predict success of implantation for day 3 human embryos |
| Q46514489 | A Canary in the Coal Mine: Reproductive Health and Cardiovascular Disease in Women |
| Q35580871 | A changing perspective: improving access to fertility preservation |
| Q35853167 | A characterization of the relationship of ovarian reserve markers with age |
| Q34827281 | A lower antral follicle count is associated with infertility |
| Q40350313 | A new era in the ethics of human embryonic stem cell research |
| Q36159645 | A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders |
| Q46788717 | A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols. |
| Q36219539 | A quantitative assessment of follicle size on oocyte developmental competence |
| Q43465428 | A short study in the treatment of hot flashes with buccal administration of 17-beta estradiol |
| Q35563872 | Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer |
| Q34547823 | Adverse childhood experiences and repeat induced abortion |
| Q46484480 | Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population |
| Q45062761 | Age-stratified thresholds of anti-Müllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold |
| Q45074681 | Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility |
| Q35533326 | Antral follicle count: absence of significant midlife decline |
| Q51252144 | Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. |
| Q43200166 | Asian ethnicity in anonymous oocyte donors is associated with increased estradiol levels but comparable recipient pregnancy rates compared with Caucasians |
| Q80185427 | Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States |
| Q38911375 | Assisted reproductive technology: moving forward--or just moving? |
| Q61037241 | Association among depression, symptom experience, and quality of life in polycystic ovary syndrome |
| Q38981509 | Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer |
| Q90497767 | Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women Are Explained by Body Mass Index |
| Q36288910 | Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study |
| Q46043935 | Author Correction: A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols |
| Q92284462 | Back-to-back random-start ovarian stimulation prior to chemotherapy to maximize oocyte yield |
| Q39734053 | Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome |
| Q44419184 | Bed rest after embryo transfer: a randomized controlled trial |
| Q56979817 | Best practices of ASRM and ESHRE: a journey through reproductive medicine |
| Q38150255 | Biomarkers of ovarian reserve--do they predict somatic aging? |
| Q35137230 | Birth weight and childhood growth in daughters of women with irregular menstrual cycles |
| Q55174705 | Cancer survivors of gynecologic malignancies are at risk for decreased opportunity for fertility preservation. |
| Q57486390 | Cardiovascular health and ovarian aging |
| Q34850830 | Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance |
| Q37006559 | Childhood adversity and pubertal timing: understanding the origins of adulthood cardiovascular risk |
| Q93246845 | Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study |
| Q39948419 | Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome: Associations With Quality of Life and Depression |
| Q33670257 | Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning |
| Q36791430 | Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California |
| Q51104680 | Continuous quality improvement and assisted reproductive technology multiple gestations: some progress, some answers, more questions. |
| Q88171805 | Contraception--when did something so right go so wrong? |
| Q44110490 | Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy loss |
| Q40155093 | Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome |
| Q45998044 | Day 2 transfer improves pregnancy outcome in in vitro fertilization cycles with few available embryos. |
| Q58597665 | Decision-making surrounding the use of preimplantation genetic testing for aneuploidy reveals misunderstanding regarding its benefit |
| Q58551870 | Declining Fertility with Reproductive Aging: How to Protect Your Patient's Fertility by Knowing the Milestones |
| Q89135549 | Decreased clinical pregnancy and live birth rates after short interval from delivery to subsequent assisted reproductive treatment cycle |
| Q34392414 | Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society |
| Q93096526 | Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis |
| Q36301456 | Depressive symptomatology, psychological stress, and ovarian reserve: a role for psychological factors in ovarian aging? |
| Q50083778 | Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study |
| Q45965498 | Diminished ovarian reserve. How do you diagnosis it? What does it mean? |
| Q36854267 | Disruptions in ovarian function are related to depression and cardiometabolic risk during premenopause |
| Q28391817 | Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? |
| Q36658976 | Dynamic secretion during meiotic reentry integrates the function of the oocyte and cumulus cells |
| Q37107300 | Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study |
| Q82273920 | Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology |
| Q46459277 | Effective method for emergency fertility preservation: random-start controlled ovarian stimulation |
| Q28547748 | Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study |
| Q90942030 | Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial |
| Q38371598 | Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). |
| Q43484015 | Egg Donor Informed Consent Tool (EDICT): development and validation of a new informed consent tool for oocyte donors |
| Q45863831 | Ethnic variation in estradiol metabolism in reproductive age Asian and white women treated with transdermal estradiol |
| Q102336389 | Factors associated with worse cerebrovascular function in aging women with and at risk for HIV |
| Q92070375 | Families with children resulting from ART: psychosocial and financial implications |
| Q38517594 | Fellowship training and board certification in reproductive endocrinology and infertility |
| Q40716717 | Fertility Sparing Surgery for Localized Ovarian Cancers Maintains an Ability to Conceive, but is Associated With Diminished Reproductive Potential |
| Q37357809 | Fertility potential in thalassemia major women: current findings and future diagnostic tools |
| Q90873338 | Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation |
| Q33640906 | Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States |
| Q43743387 | Fertilization rate is an independent predictor of implantation rate |
| Q46021835 | Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial. |
| Q36248349 | Follicular fluid steroid hormone levels are associated with fertilization outcome after intracytoplasmic sperm injection |
| Q38870669 | Fresh versus frozen: initial transfer or cumulative cycle results: how do we interpret results and design studies? |
| Q36315273 | Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities |
| Q35671932 | Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women |
| Q46084579 | Gonadotropin stimulation demonstrates a ceiling effect on in vitro fertilization outcomes |
| Q98944292 | Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction |
| Q28247441 | Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma |
| Q34072002 | Human primordial germ cell formation is diminished by exposure to environmental toxicants acting through the AHR signaling pathway |
| Q90997728 | Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback |
| Q43836522 | Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation |
| Q89050912 | Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes |
| Q37387906 | Importing human pluripotent stem cell lines derived at another institution: tailoring review to ethical concerns |
| Q92365995 | Improved diagnostic performance for the diagnosis of polycystic ovary syndrome using age-stratified criteria |
| Q44660680 | In vitro fertilization and risk of autistic disorder and mental retardation |
| Q98212333 | Increased body mass index is associated with a non-dilutional reduction in antimullerian hormone |
| Q91766355 | Increasing NIH Funding for Academic Departments of Obstetrics and Gynecology: A Call to Action |
| Q46514580 | Informed consent in human oocyte, embryo, and embryonic stem cell research |
| Q61037242 | Insulin resistance is associated with depression risk in polycystic ovary syndrome |
| Q89062619 | Interpregnancy Interval and Singleton Live Birth Outcomes From In Vitro Fertilization |
| Q92904836 | Interpregnancy interval and singleton pregnancy outcomes after frozen embryo transfer |
| Q35784740 | Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). |
| Q46718804 | Introduction: Childhood implications of parental aging |
| Q44546462 | Introduction: menopausal hormone therapy: where are we today? |
| Q40798586 | Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies. |
| Q43276818 | Is antral follicle count a genetic trait? |
| Q91603375 | Is in utero exposure to maternal socioeconomic disadvantage related to offspring ovarian reserve in adulthood? |
| Q90901971 | Links between age at menarche, antral follicle count, and body mass index in African American and European American women |
| Q46366566 | Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield |
| Q39165361 | Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study |
| Q46803037 | Luteal phase estrogen is decreased in regularly menstruating older women compared with a reference population of younger women |
| Q44876538 | Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression |
| Q46116988 | Medicine. Consent from donors for embryo and stem cell research |
| Q49893742 | Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial |
| Q34571805 | Menstrual irregularity and cardiovascular mortality |
| Q36434709 | Metaphase II (MII) oocytes obtained at different time points in the same in vitro fertilization cycle |
| Q42514142 | Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity |
| Q90209886 | Microfluidic sorting selects sperm for clinical use with reduced DNA damage compared to density gradient centrifugation with swim-up in split semen samples |
| Q45199352 | National reporting of in vitro fertilization success rates: how do we get patients useful information? |
| Q36826905 | Neighborhood socioeconomic status during childhood versus puberty in relation to endogenous sex hormone levels in adult women |
| Q96343278 | Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes |
| Q35012108 | Novel missense mutations of the Deleted-in-AZoospermia-Like (DAZL) gene in infertile women and men. |
| Q94585847 | Obesity and depression are risk factors for future eating disorder-related attitudes and behaviors in women with polycystic ovary syndrome |
| Q46347431 | Oocyte degeneration after intracytoplasmic sperm injection: a multivariate analysis to assess its importance as a laboratory or clinical marker |
| Q45948397 | Oocyte donors' comprehension as assessed by the EDICT (Egg Donor Informed Consent Tool). |
| Q40502677 | Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community |
| Q37810024 | Ovarian Hyperstimulation Syndrome Prevention Strategies: Reducing the Human Chorionic Gonadotropin Trigger Dose |
| Q49606729 | Ovarian aging is associated with gray matter volume and disability in women with MS. |
| Q33742664 | Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study |
| Q92515179 | Ovarian stimulation and egg retrieval in the acutely ill patient: special considerations |
| Q92763349 | Ovarian stimulation for fertility preservation or family building in a cohort of transgender men |
| Q46532194 | Patient willingness to participate in a clinical trial with preimplantation genetic diagnosis |
| Q34655669 | Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study |
| Q46432495 | Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations |
| Q45063803 | Plasma homocysteine levels after hormone therapy with and without folic acid supplementation: a randomized study |
| Q56929496 | Polycystic Ovary Syndrome and Risk for Long-Term Diabetes and Dyslipidemia |
| Q38383203 | Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children |
| Q90801516 | Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis |
| Q34698200 | Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia |
| Q75257971 | Polycystic ovary syndrome: what is it and how should we treat it? |
| Q83138325 | Postmenopausal hormone therapy: new questions and the case for new clinical trials |
| Q83681060 | Practice patterns and outcomes with the use of single embryo transfer in the United States |
| Q94585834 | Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins |
| Q36368086 | Preimplantation genetic diagnosis does not increase pregnancy rates in patients at risk for aneuploidy |
| Q46027773 | Preimplantation genetic screening in older women: a cost-effectiveness analysis. |
| Q35605936 | Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer |
| Q46289276 | Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features |
| Q46083562 | Prevalence of celiac disease in a cohort of women with unexplained infertility |
| Q36293496 | Pubertal timing, androgens, and obesity phenotypes in women at midlife |
| Q40858171 | Putative role for insulin resistance in depression risk in polycystic ovary syndrome. |
| Q37685259 | Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women |
| Q34021548 | Racial and ethnic disparities in reproductive endocrinology and infertility |
| Q36069501 | Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer |
| Q45958781 | Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk. |
| Q35212404 | Reproductive capacity in iron overloaded women with thalassemia major |
| Q33943067 | Research ethics. NIH guidelines for stem cell research and gamete donors |
| Q38999007 | Response to ovarian stimulation is not impacted by a breast cancer diagnosis |
| Q46412520 | Rotterdam criteria-based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study |
| Q36736281 | Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS) |
| Q37017086 | Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines |
| Q58588799 | Sex Hormone Levels by Presence and Severity of Cirrhosis in Women With Chronic Hepatitis C Virus (HCV) Infection |
| Q58104425 | Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation |
| Q33913224 | Socioeconomic disparities in the use and success of fertility treatments: analysis of data from a prospective cohort in the United States. |
| Q33790796 | Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes |
| Q38746129 | Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife |
| Q100430148 | Testosterone is Associated With Nonalcoholic Steatohepatitis (NASH) and Fibrosis in Pre-Menopausal Women With NAFLD |
| Q90963879 | The American Gynecological and Obstetrical Society-reinvigorating for the 21st century |
| Q90970446 | The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome |
| Q35200989 | The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition |
| Q92792068 | The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? |
| Q35946610 | The clinical need for a method of identification of embryos destined to become a blastocyst in assisted reproductive technology cycles |
| Q89946149 | The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial |
| Q47677866 | The effect of early fetal losses on singleton assisted-conception pregnancy outcomes |
| Q44770567 | The effect of early fetal losses on twin assisted-conception pregnancy outcomes |
| Q37184268 | The effect of follicular fluid hormones on oocyte recovery after ovarian stimulation: FSH level predicts oocyte recovery |
| Q57790887 | The efficiency of single institutional review board review in National Institute of Child Health and Human Development Cooperative Reproductive Medicine Network-initiated clinical trials |
| Q34262427 | The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance |
| Q46319365 | The role of anti-müllerian hormone (AMH) in assessing ovarian reserve |
| Q36106414 | The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer |
| Q64124172 | The sixth vital sign: what reproduction tells us about overall health. Proceedings from a NICHD/CDC workshop |
| Q24632194 | The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States |
| Q24626206 | Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes |
| Q61037243 | To freeze or not to freeze: decision regret and satisfaction following elective oocyte cryopreservation |
| Q48685403 | Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis |
| Q34486094 | Triphasic oral contraceptives: review and comparison of various regimens |
| Q46660054 | Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation |
| Q46560031 | Variants in Deleted in AZoospermia-Like (DAZL) are correlated with reproductive parameters in men and women |
| Q41138360 | Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure |
| Q38517921 | Who are we? A perspective on the reproductive endocrinologist and infertility specialist in the 21st century |
| Q35584349 | Will imatinib compromise reproductive capacity? |
| Q46152674 | Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls. |
| Q80378200 | Women, hormones, and clinical trials: a beginning, not an end |